Malawi National AIDS Commissions joins global experts in describing this as a pivotal moment on the road to ending AIDS as a public health threat— ensuring lifesaving innovation reaches those who need it most, wherever they live. The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed...
Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir (LEN) as Pre-Exposure Prophylaxis. The drug needs to be injected just twice a year for the HIV Negative at-risk population groups. The approval means the drug could be rolled out globally to help overcome barriers...
The UNAIDS Joint Programme Plan for Malawi for 2025-2030 has been unveiled. The program focuses on ending AIDS as a public health threat by 2030. This program builds upon the National Strategic Plan for HIV and AIDS (2023-2025) and aims to accelerate progress towards the 95-95-95 targets, ensuring that most people living with HIV know...
